Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Beclometasone pressurised metered-dose inhaler - Chiesi

Drug Profile

Beclometasone pressurised metered-dose inhaler - Chiesi

Alternative Names: BDP Modulite®; Beclazone Modulite; Beclazone Modulite Easi-Breathe; Beclojet 250 HFA; Beclometasone HFA inhalation - Chiesi; Beclometasone Modulite; Beclometasone pMDI; Beclomethasone HFA inhalation - Chiesi; Beclomethasone hydrofluoroalkane inhalation - Chiesi; Beclomethasone Modulite; CHF 781; Clenil Modulite; HFA Beclomethasone Dipropionate

Latest Information Update: 01 Feb 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi Farmaceutici
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 05 Dec 2018 Chiesi Farmaceutici completes the phase II BEAM trial in Asthma in USA (Inhalation) (NCT03084718)
  • 28 Jul 2017 Phase-II clinical trials in Asthma in USA (Inhalation) (NCT03084718)
  • 23 Mar 2017 Chiesi plans a phase II trial for Asthma in USA (Inhalation) (NCT03084718)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top